インターヴェンショナル画像下システムの世界市場2017-2021...市場調査レポートについてご紹介

Table of Contents
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
• Key market highlights

PART 05: Market landscape
• Market overview
• Five forces analysis

PART 06: Market segmentation by product
• Interventional CT image-guided systems
• Interventional X-ray and fluoroscopy image-guided systems
• Interventional MRI image-guided systems
• Interventional PET image-guided systems
• Interventional ultrasound image-guided systems
• Interventional endoscope image-guided systems
• Interventional SPECT image-guided systems

PART 07: Market segmentation by application
• Cardiology
• Oncology
• Orthopedic and neurology
• Gastroenterology and urology

PART 08: Market segmentation by end-user
• Hospitals and clinics
• ASCs
• Diagnostic centers

PART 09: Geographical segmentation
• Interventional image-guided systems in Americas
• Interventional image-guided systems in EMEA
• Interventional image-guided systems in APAC

PART 10: Decision framework

PART 11: Drivers and challenges
• Market drivers
• Impact of drivers on key customer segments
• Market challenges
• Impact of challenges on key customer segments

PART 12: Market trends
• New product launches with technological advances
• Integration of robotic surgical platform and hybrid operating room equipment
• Rise in funding

PART 13: Vendor landscape
• Competitive landscape

PART 14: Key vendor analysis
• GE Healthcare
• Olympus
• Philips Healthcare
• Siemens Healthineers
• Toshiba Medical Systems
• Key companies to watch
• Other prominent vendors

PART 15: Appendix
• List of abbreviations

[List of Exhibits]

Exhibit 01: Types of interventional image-guided systems and their applications
Exhibit 02: Market overview: Global interventional image-guided systems market
Exhibit 03: Global interventional image-guided systems market 2016-2021 ($ billions)
Exhibit 04: Opportunity analysis of global interventional image-guided systems market
Exhibit 05: Global interventional image-guided systems market: Market impact analysis in present and future scenario
Exhibit 06: Five forces analysis
Exhibit 07: Global interventional image-guided systems by product in 2016
Exhibit 08: Market overview: CT image-guided systems
Exhibit 09: Global interventional CT image-guided systems market 2016-2021 ($ millions)
Exhibit 10: Market overview: Interventional X-ray and fluoroscopy image-guided systems
Exhibit 11: Global interventional X-ray fluoroscopy image-guided systems market 2016-2021 ($ millions)
Exhibit 12: Market overview: Interventional MRI image-guided systems
Exhibit 13: Global Interventional MRI image-guided systems market 2016-2021 ($ millions)
Exhibit 14: Market overview: Interventional PET image-guided systems
Exhibit 15: Global interventional PET image-guided systems market 2016-2021 ($ millions)
Exhibit 16: Market overview: Interventional ultrasound image-guided systems
Exhibit 17: Global interventional ultrasound image-guided systems market 2016-2021 ($ millions)
Exhibit 18: Market overview: Interventional endoscope image-guided systems
Exhibit 19: Global Interventional endoscope image-guided systems market 2016-2021 ($ millions)
Exhibit 20: Market overview: Interventional SPECT image-guided systems
Exhibit 21: Global interventional SPECT image-guided systems market 2016-2021 ($ millions)
Exhibit 22: Global interventional image-guided systems market by application in 2016
Exhibit 23: Cardiology: Interventional image-guided systems
Exhibit 24: Oncology: Interventional image-guided systems
Exhibit 25: Orthopedic and neurology: Interventional image-guided systems
Exhibit 26: Gastroenterology and urology: Interventional image-guided systems
Exhibit 27: Global interventional image-guided systems market by end-user in 2016
Exhibit 28: Global interventional image-guided systems by geographical segmentation in 2016 ($ millions)
Exhibit 29: Market overview: Interventional image-guided systems in Americas
Exhibit 30: Number of coronary angiography in few countries in Americas 2013
Exhibit 31: Interventional image-guided systems market in Americas 2016-2021 ($ billions)
Exhibit 32: Interventional image-guided systems market in Americas: Market analysis in various countries
Exhibit 33: Market overview: Interventional image-guided systems in US
Exhibit 34: Market overview: Interventional image-guided systems in EMEA
Exhibit 35: Colorectal cancer mortality (per 100,000 population) in European countries 2003 and 2013
Exhibit 36: Interventional image-guided systems market in EMEA 2016-2021 ($ millions)
Exhibit 37: Interventional image-guided systems market in EMEA: Market analysis in various countries
Exhibit 38: Market overview: Interventional image-guided systems in UK
Exhibit 39: Market overview: Interventional image-guided systems in APAC
Exhibit 40: Colorectal cancer mortality (per 100,000 population) in APAC countries 2003 and 2013
Exhibit 41: Interventional image-guided systems market in APAC 2016-2021 ($ millions)
Exhibit 42: Interventional image-guided systems market in APAC: Market analysis in various countries
Exhibit 43: Market overview: Interventional image-guided systems in Japan
Exhibit 44: Novel technologies in hybrid imaging and platforms for image-guided systems
Exhibit 45: Fall and hip fracture cases in US in 2016
Exhibit 46: Number of road injuries in UK in 2015
Exhibit 47: Coronary and procedure reimbursement by Medicare in ASCs
Exhibit 48: Physician payment by Medicare for cardiology procedures
Exhibit 49: Impact of drivers
Exhibit 50: Comparison between diagnostic and image-guided MRI procedures
Exhibit 51: Impact of challenges
Exhibit 52: Product launches in global interventional image-guided systems market
Exhibit 53: Number of hospitals merged and acquired from 2010 to 2015 in US
Exhibit 54: Competitive structure analysis of global interventional image-guided systems market
Exhibit 55: Competitive landscape analysis of global interventional imageguided systems market 2016
Exhibit 56: GE Healthcare: Key highlights
Exhibit 57: GE Healthcare: Strength assessment
Exhibit 58: GE Healthcare: Strategy assessment
Exhibit 59: GE Healthcare: Opportunity assessment
Exhibit 60: Olympus: Key highlights
Exhibit 61: Olympus: Strength assessment
Exhibit 62: Olympus: Strategy assessment
Exhibit 63: Olympus: Opportunity assessment
Exhibit 64: Philips Healthcare: Key highlights
Exhibit 65: Philips Healthcare: Strength assessment
Exhibit 66: Philips Healthcare: Strategy assessment
Exhibit 67: Philips Healthcare: Opportunity assessment
Exhibit 68: Siemens Healthineers: Key highlights
Exhibit 69: Siemens Healthineers: Strength assessment
Exhibit 70: Siemens Healthineers: Strategy assessment
Exhibit 71: Siemens Healthineers: Opportunity assessment
Exhibit 72: Toshiba Medical Systems: Key highlights
Exhibit 73: Toshiba Medical Systems: Strength assessment
Exhibit 74: Toshiba Medical Systems: Strategy assessment
Exhibit 75: Toshiba Medical Systems: Opportunity assessment
Exhibit 76: Key companies to watch in global interventional image-guided systems market
Exhibit 77: Other prominent vendors